Pregnancy claims
This article was originally published in The Tan Sheet
Executive Summary
FDA will hold a public meeting March 30 on safety issues related to dietary supplement use during pregnancy. In a notice to be published in the Feb. 24 Federal Register, FDA seeks comments on five points: potential maternal and fetal hazards associated with supplement use for pregnancy-related conditions; existence of certain pregnancy-related conditions for which structure/function claims should be permitted; potential harm of using supplements during pregnancy for conditions unrelated to pregnancy; means of addressing safety concerns associated with supplement use during pregnancy; and use of specific warnings on supplements for pregnancy-related conditions. The meeting is 9 a.m. to 5 p.m. at the Hilton in Gaithersburg, Md.; comments are due within 60 days of the Federal Register notice date
You may also be interested in...
Supplements Pregnancy Warning Statement Petition Pending From CHPA
The inclusion of a pregnancy/nursing warning on dietary supplement labeling is encouraged by the Consumer Healthcare Products Association in a new voluntary labeling program for its members.
Supplements Pregnancy Warning Statement Petition Pending From CHPA
The inclusion of a pregnancy/nursing warning on dietary supplement labeling is encouraged by the Consumer Healthcare Products Association in a new voluntary labeling program for its members.
Supplements Pregnancy Warning Statement Petition Pending From CHPA
The inclusion of a pregnancy/nursing warning on dietary supplement labeling is encouraged by the Consumer Healthcare Products Association in a new voluntary labeling program for its members.